THIOTHIXENE Drug Patent Profile
✉ Email this page to a colleague
When do Thiothixene patents expire, and what generic alternatives are available?
Thiothixene is a drug marketed by Am Therap, Amneal, Chartwell Rx, Epic Pharma Llc, Novitium Pharma, Rising, Watson Labs, Alpharma Us Pharms, Paco, Teva, Teva Pharms, and Hikma. and is included in twenty-two NDAs.
The generic ingredient in THIOTHIXENE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.
Summary for THIOTHIXENE
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 22 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 4 |
Patent Applications: | 5,112 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for THIOTHIXENE |
DailyMed Link: | THIOTHIXENE at DailyMed |
Recent Clinical Trials for THIOTHIXENE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lindner Center of HOPE | Phase 2 |
Janssen Scientific Affairs, LLC | |
Drug Safety and Effectiveness Network, Canada |
Pharmacology for THIOTHIXENE
Drug Class | Typical Antipsychotic |